Sunteți pe pagina 1din 7

Corporate Office : Mahendra Industrial Estate,

=D

Aarti Drugs Limited


Manufacturers of : Bulk Drugs & Chemicals

Plot No. 109-D, Road No, 29, Sion (East),


Mumbai - 400 O22. (India)
Iel.: 022-2407 2249 | 24Ot 9025 (30 Lines)
Fax: 022-2407 3462 / 2407 0144
Email : audit@aartidrugs.com
Website : www.aartidrugs.com

CIN NO : 137060MH1984P1C05s433

Ref: ADL/SE/201'6-17
Date: 9tt November, 201'6

To,
Department of CorPorate Services
BSE Limited
Phiroze jeejeebhoy Towers,

Dalal Street,
Mumbai - 400 001
BSE CODE -524348
BSE ID - AARTIDRUGS

National Stock Exchange of India


Limited
"Exchange Plaza",
Bandra - Kurla ComPlex,
Bandra(E), Mumbai - 400 051
NSE CODE: AARTIDRUGS

Sub: Outcome of Board Meeting held today i.e. 9th November,20L6 pursuant to
Regulation 33 and Regulgtion 30 read with Para A of Part A of Schedule III
of SEBI (Listing Obligations & Disclosure Requirements) Regulations,20Ll
Dear Sir,

pursuant to Regulation 33 and Regulation 30 read with Para A of Part A of Schedule


III of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, we
inform you that the Board of Directors at its Meeting held today i.e. Wednesday, 9ft
November, 20'!.6 had, inter-alla considered and approved the Audited Financial
Results (Standalone & Consolidated) for the Quarter & Hatf year ended 30th
September , 20'1,6. Accordingly, please find enclosed herewith Statement of Audited
Financial Results (Standalone & Consolidated) for the Quarter & Half year ended on
30ft september,2016 alongwith report of the statutory Auditors.
The meeting conunenced at 12.30 p.m' and concluded at 1'50 p'm'

The above

is for your kind

information and records. You are requested to

acknowledge the receiPt.

Thanking you,
Yours faithfully,
For Aarti Drugs Limited

Vibhav

S. Ranade

Company Secretary & Compliance Officer


Encl: A/A

Regd. Office : Plot No. N-198, MIDC, Tarapuri Tal-Palghar, Dist. Palghar - 401 506. (MH)

Corporate Office : Mahendra Industrial Estate,

=t

ll=

Aarti Drugs Limited

Manufacturers of : Bulk Drugs & Chemicals

Plot No. 109-D, Road No. 29, Sion (East),


Mumbai - 400 022. (India)
Tel.: 022-24O7 2249 / 24OI 9025 (30 Lines)
Fax:022-2407 3462 | 2407 Ot44
Email ; admin@aartidrugs.com
Website : www.aartidrugs.com
CIN NO : 137060MH1984P1C055433

STATEMENT OF AUDITED FINANCIAL RESULTS FOR THE QUARTER AND


PERIOD ENDED 3OTH SEP, 2016

Income

fron Operations

(a) Gross Sales / Income from Operations


: Excise Duty & S6les Tax
(a) Net Sales / In@me from Ooerations
(Net Of Excise Duty & Sates Tax)
(b) Other Operating Income

Expnditure
(s) CoS of materials consumed
(b) Purchase of stock-in-tEde
(c) Changes in inventories offinished goods,
work-in-progre$ and stock-in-trade
(d) Employee benfils expense
(e) Deprecialion and Amorlisalion Expense
(f) Other expenses

Profit from Opentions befo.e Othe. Income.


linance costs and exceptionat items
tf-Zt

Profittrom ordinary activities before finance

cost I

3,832

g.E32

Profit faom ordinary activities afterlinance cost


but beforc ExceDtional ltems
Exceptional ltems
Profit f.om Ordinary Activities befo.e Tax
{7-g)

Provision forTaxalion - Curent


- MAT Credit Entiilement
- Earlier year
Prcvision for Defered Taxalion

protit f.om otdinary Activities afteJ

Tax

(9-iO)

Profit for lhe Period afteltaxes, minodty interest


share of profiU (loss) ofassociates

Equity Shere Capital of Rs 10/- oach


& Surplus (excluding revalualion reseryes)

FoT AARTI DRUGS LIMITED

Place: Mumbai

Date: 9th November.2016

HARSHIT M. SAVI.A

JT. MANAGING DIRECTOR

Regd' office : Plot No. N-r98, MIDc, Tarapur, Tal-palghar; Dist. palghar - 401 506. (MH)

Corporate Office : Mahendra Industrial Estate.

Aarti Drugs Limited


Manufacturers of : Bulk Drugs & Chemicals

(a) Share capital


(b) Reserves and surplus

Total - Shareholders's funds


Non-current liabilities
(a) Long - term borrowings
(b) Deferred tax liabitities (net)
(c) Other long - term liabilities
(d) Long - term provisions
Total - Non - current liabilities

(b) Trade payabtes


(c) Other current liabilities
(d) Short - term provisions

Total

- current liabilities

Plot No. 109-D, Road No. 29, Ston (East),


Mumbai - 4O0 022. (India)
Tel.:022-2407 2249 I 2401 9025 (30 Lines)
Fax:022-2407 3462 / 2407 OL44
Email : admin@aartidrugs.com
Website : www.aaftidrugs.com
CIN NO : 137060MH1984P1C055433

2,422
36,354
38,775

35,031

17,617

17,521

4,321

2,422
32,610

2,422
37,508
39,930

2,422
33,318
35,740

19,144
4,338

19,123

4,041

615
772

561
142

8.16

23,326

zztzoc

24,934

23,911

21,872
18,305
4,461
1,369

25,737

21,999
20,706
4,617
1,477

25,841
18,490
4,847

52,695
1,015
438
54,149

49,68't

55,793
367
68u
56,840

52,746
463
488
53,697

1 8,1 85
30,374
235

16,705
32,120
450
1,884
3,045
54,203

19,817
31,431

33,1 69

16,41 8

4,690
|

,JZO

4,042
ouc

142

, ?or

TOTAL. EQUITY AND LIABILITIES

(a) Fixed assets ( inctuding CWtp)


(b) Non - current investments
(c) Long - term loans and advances

Total

Non - current assets

(a) Inventories
(b) Trade receivables
(c) Cash and cash equivalents
(d) Short - term loans and advances
(e) Other -current assets

Total

Notes

current assets

2,325
2,840
53,960

1,112
474
51,267

17,835

zc6

482

2,412

2,904

1,924
a 41a

56,823

56,522

The above results for the quarter and period ended 3oth september, 2016
have been reviewed by the Audit committee and approved by
the Board of
Directors in their meeting held on gth November, 2016.

2 company

is operating as a singre segment company, engaged in pharmaceuticar


business

3 Figures for the previous period /year have been regrouped or rearranged wherever necessary
4 The aforesaid Audited Financial Results will be uploaded on the company's
website www.aartidrugs.com and will also be available on the website
of
BSE Limited www bseindia com and the NationaL stock Exchange
of India Limited www.nseindia.com for the benefit of the shareholders
and investors

For AARTI DRUGS LtM|TED

Place: Mumbai
Date: gth November,2016

uN-1,
HARSHIT M. SAVLA
JT. MANAGING DIRECTOR

Regd. office : Plot No. N-198, MIDC, Tarapur, Tal-pa19har, Dist. palghar - 40r 506. (MH)

gokhale

sathe
(regd.)

chartered accountants
308/309, udyog mandir no. 1,
7-c, bhagoji keer marg,
mahim, mumbai 400 016.

Auditor's Report on Quarterly and Year to Date Standalone Financial Results of


AARTI DRUGS LIMITED Pursuant to the Regulation 33 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015

To
The Board of Directors of AARTI DRUGS LIMITED

We have audited the quarterly standalone financial results of AARTI DRUGS LIMITED

('the Company') for the quarter ended September 30,2016 and the year to date standalone

financial results for the period from April

l,

2016

to

September 30, 2016, attached

herewith, being submitted by the Company pursuant to the requirement of Regulation 33

of

the SEBI (Listing Obligations and Disclosure Requirements) Regulations,20l5.

llhese standalone quarterly as well as year to date financial results have been prepared on
the basis of the interim financial statements, which are the responsibility of the company's
rnanagement. Our responsibility is to express an opinion on these financial results based on

our audit of such interim standalone financial statements, which have been prepared in
accordance

with the recognition and measurement principles laid down in Accounting

Standard (AS) 25, on Interim Financial Reporting, specif,red under section 133

of

the

Companies Act,2013 read with Rule 7 of the Companies (Accounts) Rules, 2014 and other
accounting principles generally accepted in India.

'We

conducted our audit in accordance with the auditing standards generally accepted in

India. Those standards require that we plan and perform the audit to obtain reasonable
a.ssurance about whether the financial results are free

of material misstatement(s). An audit

includes examining, on a test basis, evidence supporting the amounts disclosed as financial

results.

,{n audit also includes

assessing

the accounting principles used and significant

estimates made by management. We believe that our audit provides a reasonable basis

our opmlon.

'MU
?e

xY?t'
a>{v0

tel.'. (22) 43 48 42

42 |

f ax : (221

a3 48 42

41 |

office@gokhalesathe.in

for

gokhale B sathe
(regd.)
chartered accountantS

In our opinion and to the best of our information and according to the explanations given to
us these quarterly and year to date standalone financial results:

(i)

are presented

in accordance with the requirements of Regulation 33 of the SEBI

(Listing Obligations and Disclosure Requirements) Regulations, 2015

in

this

regard; and
(iD

give a true and fair view of the net profit and other financial information for the
quarter ended September 30,2016 as well as the year to date results for the period

from April 1,2016 to September 30, 2016.


For GOKHALE & SATHE
CHARTERED ACCOUNTANTS
Firm Registration No.: 103264W

CA TEJAS PARIKH
PAR.TNER
M. No. 123215
Mumbai,
Date:November 9, 2016.

gokhale l sathe
(regd.)

chartered accountants
308/309, udyog mandir no. 1,
7-c, bhagoji keer marg,
mahim. mumbai 400 016.

Auditor's Report on Quarterly and Year to Date Consolidated Financial Results of


1\ARTI DRUGS LIMITED Pursuant to the Regulation 33 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations' 2015

T'o

Etoard of Directors of

AARTI DRUGS LIMITED.

We have audited the quarterly consolidated financial results of AARTI DRUGS LIMITED
("'the Company") for the quarter ended September 30, 2016 and the year to date
consolidated financial results for the period from April l, 2016 to September 30, 2016,
attached herewith, being submitted by the Company pursuant to the requirement of
tri.egulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,

2115.
llhese quarterly as well as year to date consolidated financial results have been prepared
from consolidated interim financial statements, which are the responsibility of the
Company's management. Our responsibility is to express an opinion on these consolidated
financial results based on our audit of such consolidated interim financial statements, which
hLave been prepared in accordance with the recognition and measurement principles laid
dlown in Accounting Standard (AS) 25, on Interim Financial Reporting, specified under
section 133 of the Companies Act, 2013 rcad with Rule 7 of the Companies (Accounts)
trlules, 2014 and other accounting principles generally accepted in India.

We conducted our audit in accordance with the auditing standards generally accepted in
India. Those standards require that we plan and perform the audit to obtain reasonable
assurance about whether the financial results are free of material misstatement(s). An audit
includes examining, on a test basis, evidence supporting the amounts disclosed as financial
results. An audit also includes assessing the accounting principles used and significant
estimates made by management. We believe that our audit provides a reasonable basis for
o,ur opinion.

tel.: (22) 43 48 4212

tax : (221 a3 48 42 41

office@gokhalesathe.in

gokhale B sathe
(regd.)
chartered accountants

30th September 2016"

total

reve s of Rs.3739.65 lakhs and Rs.7631.52 lakhs for the

quarter ended and for six months ended 30ft September 2016 respectively, as considered in
tlhe consolidated financial statements. These financial statements/ financial information
hLave been audited by other auditor whose report have been furnished to us and our opinion
o,n the consolidated financial statements, in so far as it relates to the amounts and
dlisclostres included in respect of its subsidiary is based solely on the report of the other
auditor.

In our opinion and to the best of our information and according to the explanations given to
us these quarterly consolidated financial results as well as year to date consolidated
financial results:

(i)
(ii)

include the quarterly and year to date financial results of its only subsidiary,
Pinnacle Life Science Private Limited.
have been presented in accordance with the requirements of Regulation 33 of the
SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in this
regard; and

(iiD

give a true and fair view of the consolidated net profit and other financial
information for the quarter ended September 30,2016 as well as the year to date
results for the period from April 1,2016 to September 30, 2016.

For GOKHALE

& SATHE

CHARTERED ACCOUNTANTS
Firm Registration No.: 103264W

CA TEJAS PARIKH
PARTNER
M. No. 123215
Place: Mumbai
Date: November 9, 2016.